Announcement
RE:YOU announced the launch of its Dual Path Hair Revival Serum in July 2026 and reported interim results from a randomized, double-blind study involving 190 participants. The company said the study compared its serum with topical minoxidil and was still in progress at the time of the release.
The company reported favorable 90-day measures for hair density, coverage, shedding, and participant-reported appearance. Those figures were preliminary company-reported findings, not an independent review of the full study or evidence of long-term outcomes.
RE:YOU said additional follow-up would be collected. The syndicated release also states that the findings had not been reviewed by the U.S. Food and Drug Administration and that the serum was not intended to diagnose, treat, cure, or prevent disease.
This page preserves the historical product announcement. Anyone considering treatment for hair loss should seek current clinical information and advice from a qualified professional rather than rely on a press release.